ClinicalTrials.Veeva

Menu

Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (P-PLAC 2)

U

University of South Wales

Status

Suspended

Conditions

Behavior Change Interventions
Cardiovascular Diseases
Behavior, Health
Cardiovascular Risk Factor

Treatments

Behavioral: Lifestyle Prescription (LRx)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Prescribing lifestyle changes to patients who are at risk of cardiovascular disease, may be an extremely cost effective mechanism of improving health for the individual themselves and the NHS. It is already proven that positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption can lower the risk of cardiovascular disease, as well as reduce the risk of all-cause mortality.

P-PLAC2 (Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health) is a Phase II interventional study to determine the efficacy of a Lifestyle Prescription (LRx), from the viewpoint of patients and healthcare practitioners. The study uses a mixed methods design, and full study training and support will be provided to staff involved in the recruitment of patients, through to the behaviour change consultation, and end of study.

If the study proves successful, a lifestyle prescription (LRx) could then be made available to support NHS staff throughout all disciplines (specifically those working with patients who are at risk of cardiovascular disease (CVD).

Enrollment

240 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 and over.
  • Able and willing to provide written informed consent.
  • Understands spoken and written English.

Exclusion criteria

  • Participant is unwilling or unable to provide written informed consent.
  • Participant is pregnant.
  • Participant has a diagnosed psychological disorder.
  • Participant has a drug dependency.
  • Participant is housebound, or resides in a nursing home.
  • Participant has behavioural issues or learning difficulties.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

240 participants in 2 patient groups

Control
No Intervention group
Description:
Standard care during consultations.
Intervention
Experimental group
Description:
Standard care during consultations with the addition of a physical lifestyle prescription.
Treatment:
Behavioral: Lifestyle Prescription (LRx)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems